BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 109208)

  • 1. Combined modality therapy with electron-beam irradiation and systemic chemotherapy for cutaneous T-cell lymphomas.
    Bunn PA; Fischmann AB; Schechter GP; Kumar PP; Ihde DC; Cohen MH; Fossieck BE; Gazdar AF; Matthews MJ; Eddy JL; Minna JD
    Cancer Treat Rep; 1979 Apr; 63(4):713-7. PubMed ID: 109208
    [No Abstract]   [Full Text] [Related]  

  • 2. Report of the Committee on Therapy for Mycosis Fungoides and Sézary Syndrome.
    Minna JD; Roenigk HH; Glatstein E
    Cancer Treat Rep; 1979 Apr; 63(4):729-36. PubMed ID: 109209
    [No Abstract]   [Full Text] [Related]  

  • 3. A 10-year experience with topical mechlorethamine for mycosis fungoides: comparison with patients treated by total-skin electron-beam radiation therapy.
    Vonderheid EC; Van Scott EJ; Wallner PE; Johnson WC
    Cancer Treat Rep; 1979 Apr; 63(4):681-9. PubMed ID: 109206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined therapy for patients with mycosis fungoides.
    Griem ML; Tokars RP; Petras V; Variakojis D; Baron JM; Griem SF
    Cancer Treat Rep; 1979 Apr; 63(4):655-7. PubMed ID: 109205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.
    Whittaker SJ; Foss FM
    Cancer Treat Rev; 2007 Apr; 33(2):146-60. PubMed ID: 17275192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha interferon in the therapy of cutaneous T cell lymphomas].
    Lang MH; Altmeyer P; Lodemann E; Holzmann H
    Z Hautkr; 1986 May; 61(9):599-608. PubMed ID: 3487184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current therapy concepts in cutaneous T-cell lymphomas].
    Nestle FO; Häffner AC; Schmid MH; Dummer R; Burg G
    Schweiz Med Wochenschr; 1997 Feb; 127(8):311-20. PubMed ID: 9157537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycosis fungoides and the Sézary syndrome.
    Gisselbrecht C; Dubertret L
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):73-5. PubMed ID: 8511044
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous T cell lymphomas: mycosis fungoides, Sézary syndrome and lymphomatoid papulosis--Part I.
    Safai B
    Clin Bull; 1977; 7(3):91-7. PubMed ID: 308870
    [No Abstract]   [Full Text] [Related]  

  • 10. Rational therapy for cutaneous T-cell lymphomas in the 1990s. Fact or fancy?
    Bunn PA
    Arch Dermatol; 1995 May; 131(5):603-5. PubMed ID: 7537952
    [No Abstract]   [Full Text] [Related]  

  • 11. Status report of 376 mycosis fungoides patients at 4 years: Mycosis Fungoides Cooperative Group.
    Lamberg SI; Green SB; Byar DP; Block JB; Clendenning WE; Epstein EH; Fuks ZY; Golitz LE; Lorincz AL; Michel B; Roenigk HH; Van Scott EJ; Vonderheid EC; Thomas RJ
    Cancer Treat Rep; 1979 Apr; 63(4):701-7. PubMed ID: 376140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Whole-skin electron therapy: a therapeutic concept for mycosis fungoides and Sézary syndrome. 2: Therapy].
    Herbst M
    Strahlentherapie; 1984 Mar; 160(3):154-8. PubMed ID: 6729855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose recombinant interleukin-2 in advanced cutaneous T-cell lymphoma.
    Marolleau JP; Baccard M; Flageul B; Rybojad M; Laroche L; Vérola O; Brandely M; Morel P; Gisselbrecht C
    Arch Dermatol; 1995 May; 131(5):574-9. PubMed ID: 7741545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total skin electron beam therapy may be associated with improvement of peripheral blood disease in Sézary syndrome.
    Introcaso CE; Micaily B; Richardson SK; Junkins-Hopkins JM; Yoon JS; Kim EJ; Vittorio CC; Rook AH
    J Am Acad Dermatol; 2008 Apr; 58(4):592-5. PubMed ID: 18249469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous T-cell lymphoma.
    Lansigan F; Choi J; Foss FM
    Hematol Oncol Clin North Am; 2008 Oct; 22(5):979-96, x. PubMed ID: 18954747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Modern therapy of mycosis fungoides].
    Roenigk HH
    Hautarzt; 1983 Jun; 34(6):266-72. PubMed ID: 6874333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memorials and mandates for cutaneous lymphomas.
    Heald PW
    Arch Dermatol; 2003 Jul; 139(7):926-8. PubMed ID: 12873891
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined modality therapy for cutaneous T-cell lymphoma.
    Duvic M; Lemak NA; Redman JR; Eifel PJ; Tucker SL; Cabanillas FF; Kurzrock R
    J Am Acad Dermatol; 1996 Jun; 34(6):1022-9. PubMed ID: 8647968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the art therapy of mycosis fungoides and Sézary syndrome.
    Kemme DJ; Bunn PA
    Oncology (Williston Park); 1992 Feb; 6(2):31-42; discussion 44, 47-8. PubMed ID: 1532501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible benefit of oral alitretinoin in T-lymphoproliferative diseases: a report of two patients with palmoplantar hyperkeratotic-rhagadiform skin changes and mycosis fungoides or Sézary syndrome.
    Molin S; Ruzicka T
    Br J Dermatol; 2009 Dec; 161(6):1420-2. PubMed ID: 19785592
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.